Buchumschlag

In vitro cancer cell-ECM interactions inform in vivo cancer treatment

The general progression of cancer drug development involves in vitro testing followed by safety and efficacy evaluation in clinical trials. Due to the expense of bringing candidate drugs to trials, in vitro models of cancer cells and tumor biology are required to screen drugs. There are many example...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Holle, Andrew W. (VerfasserIn) , Young, Jennifer (VerfasserIn) , Spatz, Joachim P. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2016
In: Advanced drug delivery reviews
Year: 2015, Jahrgang: 97, Pages: 270-279
ISSN:1872-8294
DOI:10.1016/j.addr.2015.10.007
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.addr.2015.10.007
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0169409X1500232X
Volltext
Verfasserangaben:Andrew W. Holle, Jennifer L. Young, Joachim P. Spatz

MARC

LEADER 00000caa a2200000 c 4500
001 1698565615
003 DE-627
005 20230427091708.0
007 cr uuu---uuuuu
008 200519r20162015xx |||||o 00| ||eng c
024 7 |a 10.1016/j.addr.2015.10.007  |2 doi 
035 |a (DE-627)1698565615 
035 |a (DE-599)KXP1698565615 
035 |a (OCoLC)1341325735 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 30  |2 sdnb 
100 1 |a Holle, Andrew W.  |e VerfasserIn  |0 (DE-588)1165158566  |0 (DE-627)1029325294  |0 (DE-576)510275540  |4 aut 
245 1 0 |a In vitro cancer cell-ECM interactions inform in vivo cancer treatment  |c Andrew W. Holle, Jennifer L. Young, Joachim P. Spatz 
264 1 |c 2016 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 17 October 2015 
500 |a Gesehen am 19.05.2020 
520 |a The general progression of cancer drug development involves in vitro testing followed by safety and efficacy evaluation in clinical trials. Due to the expense of bringing candidate drugs to trials, in vitro models of cancer cells and tumor biology are required to screen drugs. There are many examples of drugs exhibiting cytotoxic behavior in cancer cells in vitro but losing efficacy in vivo, and in many cases, this is the result of poorly understood chemoresistant effects conferred by the cancer microenvironment. To address this, improved methods for culturing cancer cells in biomimetic scaffolds have been developed; along the way, a great deal about the nature of cancer cell-extracellular matrix (ECM) interactions has been discovered. These discoveries will continue to be leveraged both in the development of novel drugs targeting these interactions and in the fabrication of biomimetic substrates for efficient cancer drug screening in vitro. 
534 |c 2015 
650 4 |a Chemoresistance 
650 4 |a Chemotherapy 
650 4 |a Extracellular matrix (ECM) 
650 4 |a Ligands 
650 4 |a Metastasis 
650 4 |a Tumor microenvironment 
700 1 |a Young, Jennifer  |e VerfasserIn  |0 (DE-588)1165167476  |0 (DE-627)1029328587  |0 (DE-576)510279120  |4 aut 
700 1 |a Spatz, Joachim P.  |d 1969-  |e VerfasserIn  |0 (DE-588)122582675  |0 (DE-627)08203124X  |0 (DE-576)173014771  |4 aut 
773 0 8 |i Enthalten in  |t Advanced drug delivery reviews  |d Amsterdam [u.a.] : Elsevier Science, 1987  |g 97(2016), Seite 270-279  |h Online-Ressource  |w (DE-627)320602346  |w (DE-600)2020327-5  |w (DE-576)255622589  |x 1872-8294  |7 nnas  |a In vitro cancer cell-ECM interactions inform in vivo cancer treatment 
773 1 8 |g volume:97  |g year:2016  |g pages:270-279  |g extent:10  |a In vitro cancer cell-ECM interactions inform in vivo cancer treatment 
856 4 0 |u https://doi.org/10.1016/j.addr.2015.10.007  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0169409X1500232X  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200519 
993 |a Article 
994 |a 2016 
998 |g 122582675  |a Spatz, Joachim P.  |m 122582675:Spatz, Joachim P.  |d 120000  |d 120300  |e 120000PS122582675  |e 120300PS122582675  |k 0/120000/  |k 1/120000/120300/  |p 3  |y j 
998 |g 1165167476  |a Young, Jennifer  |m 1165167476:Young, Jennifer  |p 2 
998 |g 1165158566  |a Holle, Andrew W.  |m 1165158566:Holle, Andrew W.  |p 1  |x j 
999 |a KXP-PPN1698565615  |e 3668644543 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Available online 17 October 2015","Gesehen am 19.05.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1698565615","person":[{"family":"Holle","given":"Andrew W.","display":"Holle, Andrew W.","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Jennifer","family":"Young","role":"aut","display":"Young, Jennifer","roleDisplay":"VerfasserIn"},{"family":"Spatz","given":"Joachim P.","roleDisplay":"VerfasserIn","display":"Spatz, Joachim P.","role":"aut"}],"title":[{"title_sort":"In vitro cancer cell-ECM interactions inform in vivo cancer treatment","title":"In vitro cancer cell-ECM interactions inform in vivo cancer treatment"}],"physDesc":[{"extent":"10 S."}],"relHost":[{"title":[{"title":"Advanced drug delivery reviews","title_sort":"Advanced drug delivery reviews"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"In vitro cancer cell-ECM interactions inform in vivo cancer treatmentAdvanced drug delivery reviews","note":["Gesehen am 14.09.2020"],"language":["eng"],"recId":"320602346","pubHistory":["1.1987 -"],"part":{"year":"2016","pages":"270-279","volume":"97","text":"97(2016), Seite 270-279","extent":"10"},"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"1987-","dateIssuedKey":"1987","publisher":"Elsevier Science"}],"id":{"issn":["1872-8294"],"zdb":["2020327-5"],"eki":["320602346"]},"physDesc":[{"extent":"Online-Ressource"}]}],"name":{"displayForm":["Andrew W. Holle, Jennifer L. Young, Joachim P. Spatz"]},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"2016"}],"id":{"eki":["1698565615"],"doi":["10.1016/j.addr.2015.10.007"]}} 
SRT |a HOLLEANDREINVITROCAN2016 

Ähnliche Einträge